ONCS
ONCS Real Time Price USDRecent trades of ONCS by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ONCS's directors and management
Government lobbying spending instances
-
$30,000 Apr 15, 2022 Issue: Health Issues
-
$30,000 Jan 15, 2022 Issue: Health Issues
-
$30,000 Oct 18, 2021 Issue: Health Issues
-
$30,000 Jul 16, 2021 Issue: Health Issues
-
$30,000 Apr 17, 2021 Issue: Health Issues
-
$30,000 Jan 15, 2021 Issue: Health Issues
-
$50,000 Oct 20, 2020 Issue: Medical/Disease Research/Clinical Labs Health Issues
-
$30,000 Oct 19, 2020 Issue: Health Issues
-
$30,000 Jul 12, 2020 Issue: Health Issues
-
$30,000 Apr 18, 2020 Issue: Health Issues
-
$30,000 Jan 18, 2020 Issue: Health Issues
-
$30,000 Oct 19, 2019 Issue: Health Issues
-
$30,000 Jul 21, 2019 Issue: Health Issues
-
$30,000 Apr 18, 2019 Issue: Health Issues
-
$30,000 Jan 18, 2019 Issue: Health Issues
-
$10,000 Oct 16, 2018 Issue: Health Issues
-
$10,000 Jan 20, 2015 Issue: Defense Health Issues
Estimated quarterly lobbying spending
ONCS Revenue by Segment or Geography
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to ONCS
Number of mentions of ONCS in WallStreetBets Daily Discussion
Recent picks made for ONCS stock on CNBC
ETFs with the largest estimated holdings in ONCS
|
Shareholder
|
Shares Held
|
|---|
- Who owns $ONCS stock?
- Who owns the most shares of $ONCS stock?
- What funds own $ONCS stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ONCS Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.